Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing reevaluation of Shengu granule for senile osteoporosis
ChiCTR2000031402Phase 4Not yet recruiting
- Sponsor
- Tongji Hospital
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Shengu Capsule in senile osteoporosis, sponsored by Tongji Hospital. Primary endpoints: Clinical symptoms and related signs of senile osteoporosis, VAS score and 3 more. Planned start Mar 2020; status: not yet recruiting.
02
Drugs
Shengu Capsule
03
Conditions
senile osteoporosis
Beyond the preview
Go deeper on ChiCTR2000031402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000031402.